| MSC for Severe aGVHD (NCT03631589) | Fujian Medical University | 2017-12-01 |
| Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer (NCT03356600) | Shanxi Province Cancer Hospital | 2017-12-01 |
| Intravenous Ketamine Plus Neurocognitive Training for Depression (NCT03237286) | Rebecca Price | 2017-12-01 |
| Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation (NCT03810391) | Shengjing Hospital | 2017-12-01 |
| Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients (NCT03315923) | Isfahan University of Medical Sciences | 2017-12-01 |
| The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients (NCT04839237) | Xiangya Hospital of Central South University | 2017-12-01 |
| Prostaglandins Before Caserean Section (NCT03366259) | Kasr El Aini Hospital | 2017-12-01 |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) (NCT03208296) | Ascend Biopharmaceuticals Ltd | 2017-12-01 |
| AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer (NCT01741038) | Mirror Biologics, Inc. | 2017-12-01 |
| QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy (NCT03197584) | ImmunityBio, Inc. | 2017-12-01 |
| A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness (NCT02948660) | Xijing Hospital | 2017-12-01 |
| Treatment of Post-Operative Sinonasal Polyposis With Topical Furosemide (NCT03362515) | Thomas Jefferson University | 2017-12-01 |
| MB-CART19.1 in Patients With R/R ALL (NCT03321123) | Shanghai Children's Medical Center | 2017-12-01 |
| QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy (NCT03167177) | ImmunityBio, Inc. | 2017-12-01 |
| Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma (NCT03077685) | NanOlogy, LLC | 2017-12-01 |
| QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy (NCT03175666) | ImmunityBio, Inc. | 2017-12-01 |
| Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors (NCT03367923) | Stanford University | 2017-12-01 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer (NCT03374293) | Shixiu Wu | 2017-12-01 |
| Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer (NCT03373760) | SWOG Cancer Research Network | 2017-11-30 |
| Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer (NCT03502850) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2017-11-30 |
| A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia (NCT03381833) | La Jolla Pharmaceutical Company | 2017-11-30 |
| Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites (NCT04785755) | Hala Abd EL-Tawab Ibrahim Radwan | 2017-11-30 |
| A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction (NCT03349866) | Hebei Medical University | 2017-11-30 |
| Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer (NCT03170115) | Instituto Nacional de Cancer, Brazil | 2017-11-30 |
| BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma (NCT03119064) | Brown University | 2017-11-30 |
| Transcranial Direct Current Stimulation to Modulate Top-Down Regulation for Drug Craving in Methamphetamine Use Disorder (NCT03382379) | Laureate Institute for Brain Research, Inc. | 2017-11-30 |
| A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer (NCT03316586) | Dana-Farber Cancer Institute | 2017-11-30 |
| A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function (NCT03357731) | Bristol-Myers Squibb | 2017-11-30 |
| Effect of Ashwagandha on Salivary Antioxidant and Serum c Reactive Protein in Chronic Generalized Periodontitis (NCT03533972) | Tatyasaheb Kore Dental College | 2017-11-30 |
| Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma (NCT03364231) | TG Therapeutics, Inc. | 2017-11-30 |
| Bioinformation Therapy for Gastric Cancer (NCT03350477) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold (NCT03339726) | Johnson & Johnson Consumer Inc. (J&JCI) | 2017-11-30 |
| Bioinformation Therapy for Intestinal Cancer (NCT03350490) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| Inotuzumab Ozogamicin in Treating Patients With Relapsed or Refractory CD22 Positive Acute Lymphoblastic Leukemia (NCT03094611) | M.D. Anderson Cancer Center | 2017-11-30 |
| Mix Vaccine for Metastatic Sarcoma Patients (NCT03357315) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC (NCT03156036) | Asan Medical Center | 2017-11-30 |
| Mix Vaccine for Metastatic Colorectal Cancer (NCT03357276) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best (NCT03373422) | Bayer | 2017-11-30 |
| Mix Vaccine for Metastatic Kidney Cancer (NCT03357289) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) (NCT03346434) | Regeneron Pharmaceuticals | 2017-11-30 |
| Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine (NCT03290963) | William V. Bobo, M.D. | 2017-11-30 |
| Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy (NCT03345134) | Shaheen Alanee | 2017-11-30 |
| A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer (NCT03314324) | Gustave Roussy, Cancer Campus, Grand Paris | 2017-11-29 |
| Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma (NCT03383237) | Henan Cancer Hospital | 2017-11-29 |
| Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer (NCT03087760) | Abramson Cancer Center at Penn Medicine | 2017-11-29 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age (NCT03303625) | Janssen Vaccines & Prevention B.V. | 2017-11-29 |
| Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) (NCT03277638) | Case Comprehensive Cancer Center | 2017-11-29 |
| Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis (NCT03222622) | Betta Pharmaceuticals Co., Ltd. | 2017-11-29 |
| Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response (NCT03373149) | Riyadh Fertility and Reproductive Health center | 2017-11-29 |
| Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity (NCT03523273) | Michael Camilleri, MD | 2017-11-29 |
| Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer (NCT03379428) | US Oncology Research | 2017-11-29 |
| GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis (NCT03474042) | Lakefront Biotherapeutics NV | 2017-11-29 |
| A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis (NCT03395704) | La Jolla Pharmaceutical Company | 2017-11-29 |
| Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma (NCT03123276) | Royal Marsden NHS Foundation Trust | 2017-11-29 |
| Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males (NCT03222401) | Alopexx Pharmaceuticals, LLC | 2017-11-29 |
| Survival Prolongation by Rationale Innovative Genomics (NCT03386929) | Worldwide Innovative Network Association | 2017-11-29 |
| Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer (NCT03389087) | Henan Cancer Hospital | 2017-11-29 |
| A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata (NCT03354637) | Aclaris Therapeutics, Inc. | 2017-11-29 |
| A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111 (NCT03507686) | Biogen | 2017-11-29 |
| Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia (NCT03263572) | M.D. Anderson Cancer Center | 2017-11-29 |
| Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy (NCT03611426) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2017-11-29 |
| Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer (NCT03507465) | Guangdong Provincial People's Hospital | 2017-11-29 |
| Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED) (NCT03173456) | Albert Einstein College of Medicine | 2017-11-28 |
| A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44 (NCT03326518) | Lument AB | 2017-11-28 |
| Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency (NCT02168686) | Adverum Biotechnologies, Inc. | 2017-11-28 |
| Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) (NCT03213678) | National Cancer Institute (NCI) | 2017-11-28 |
| Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas (NCT03231306) | University of Alabama at Birmingham | 2017-11-28 |
| PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer (NCT04151277) | Judith Dixon-Hughes | 2017-11-28 |
| Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer (NCT03386500) | University of Nebraska | 2017-11-28 |
| Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (NCT03345407) | GlaxoSmithKline | 2017-11-28 |
| A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis (NCT03355573) | UCB Biopharma SRL | 2017-11-28 |
| Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea (NCT03064438) | Accuitis, Inc. | 2017-11-28 |
| Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate (NCT03221257) | Michael Roth | 2017-11-28 |
| Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome. (NCT03723811) | Samjin Pharmaceutical Co., Ltd. | 2017-11-28 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes (NCT03406585) | NextCell Pharma Ab | 2017-11-28 |
| Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery (NCT03353259) | Oslo University Hospital | 2017-11-28 |
| Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment (NCT03827408) | Nourhan M.Aly | 2017-11-27 |
| Stereotactic Body Radiotherapy for the Treatment of OPD (NCT03256981) | Institute of Cancer Research, United Kingdom | 2017-11-27 |
| Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma (NCT03179943) | Fox Chase Cancer Center | 2017-11-27 |
| Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial (NCT03301779) | Hemanext | 2017-11-27 |
| Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL) (NCT03298893) | Institut Curie | 2017-11-27 |
| S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882) | SWOG Cancer Research Network | 2017-11-27 |
| Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer (NCT03054363) | University of Colorado, Denver | 2017-11-27 |
| A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia (NCT03187262) | Dana-Farber Cancer Institute | 2017-11-27 |
| Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b (NCT03485846) | R-Pharm | 2017-11-27 |
| Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011) (NCT03272347) | Merck Sharp & Dohme LLC | 2017-11-27 |
| An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer (NCT03351231) | Bristol-Myers Squibb | 2017-11-27 |
| A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors (NCT03266159) | GlaxoSmithKline | 2017-11-27 |
| Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma (NCT03149029) | Massachusetts General Hospital | 2017-11-27 |
| Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors (NCT03379259) | BeiGene | 2017-11-27 |
| Stem Cell Educator Therapy in Diabetes (NCT03390231) | Throne Biotechnologies Inc. | 2017-11-27 |
| Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle (NCT03079401) | Boston Children's Hospital | 2017-11-27 |
| Plinabulin iv Solution in Prevention of TAC Induced Neutropenia (NCT04227990) | BeyondSpring Pharmaceuticals Inc. | 2017-11-27 |
| Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) (NCT03331198) | Juno Therapeutics, a Subsidiary of Celgene | 2017-11-27 |
| The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome (NCT03452189) | NYU Langone Health | 2017-11-27 |
| Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy (NCT03349177) | Zhiyong Yu | 2017-11-27 |
| A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. (NCT03281876) | GlaxoSmithKline | 2017-11-27 |
| A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease (NCT02927314) | Can-Fite BioPharma | 2017-11-27 |
| T-Cell PET Imaging With [18F]F-AraG in Lung Cancer (NCT03311672) | University of California, San Francisco | 2017-11-26 |